While USA can provide profitability quickly, the real potential of Polynovo to scale up comes from its ability to meet the medical needs of people across the globe. That journey needs to be visible for SP to reflect its scale up potential relative to competitors. Unfortunately our instos are not that tech friendly in creating powerful world-class companies often stuck with classical finance.
India patient story from DW, page-11
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.57 |
Change
0.030(1.18%) |
Mkt cap ! $1.773B | |||
| Open | High | Low | Value | Volume |
| $2.60 | $2.60 | $2.55 | $1.327M | 514.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2507 | $2.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 4000 | 2 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |